| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $57.9M | +0.1% | +33.2% |
| SG&A Expense | $26.4M | -18.9% | +70.8% |
| Operating Income | -$84.3M | +6.8% | -43.1% |
| Interest Expense | $1.5M | +0.9% | +3.5% |
| Income Tax | $0 | — | — |
| Net Income | -$83.1M | +4.1% | -56.6% |
| EPS (Basic) | -$0.90 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $102.3M | +5.1% | -9.9% |
| Short-term Investments | $221.3M | -27.7% | -30.5% |
| Current Assets | $333.7M | -19.3% | -24.6% |
| Total Assets | $389.4M | -17.1% | -21.8% |
| Current Liabilities | $52.9M | -11.2% | +20.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$158.2M | -105.4% | — |
| Investing Cash Flow | $149.2M | +129.4% | — |
| Financing Cash Flow | $166K | +205.1% | — |
| -32.4% |
| EPS (Diluted) | -$0.90 | +5.3% | -32.4% |
| $47.2M |
| +0.9% |
| +3.6% |
| Total Liabilities | $126.1M | -5.0% | +8.0% |
| Stockholders' Equity | $263.3M | -21.8% | -31.0% |